Study of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic Leukemia
Clinical trial NCT04075292 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04075292
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-20
- Primary completion
- 2024-01-03
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.